Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 07.04.2021

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
07.04.21Ernst Russ - Specialising in shipping business738Ernst Russ (ERAG) continues to build its position in the maritime business with the acquisition of two ships in December 2020 and another two in February 2021. As a result, it now owns a majority interest...
► Artikel lesen
07.04.21AAC Clyde Space - Building the platforms for growth418AAC Clyde Space has agreed the proposed acquisition of Swedish scientific instrument maker Omnisys Instruments for an initial consideration of c SEK75m in a cash and equity deal. It has also undertaken...
► Artikel lesen
07.04.21Hepion Pharmaceuticals - Phase IIa readout upcoming414Despite a challenging operating environment due to COVID-19, Hepion was able to advance its CRV431 development program (for the treatment of non-alcoholic steatohepatitis, NASH) without major disruption...
► Artikel lesen
07.04.21Mondo TV - The deals keep coming359Mondo TV produced good FY20 results, with production value up by 14% to €30.4m and an uptick in EBITDA margin (on production value) from 61.4% to 61.8%. The strengthening of the balance sheet through...
► Artikel lesen
07.04.21Claranova - Profitable growth in H121299Claranova made good progress in H121, with organic constant currency revenue growth of 17% y-o-y and EBITDA growth of 106% y-o-y. Recent acquisitions made by PlanetArt are progressing well and the division...
► Artikel lesen
07.04.21Newron Pharmaceuticals - Gate not yet open to Phase III370Newron is developing evenamide as an add-on to existing anti-psychotic therapies to treat poorly managed and refractory schizophrenia. Two recently completed safety studies, one in patients and the...
► Artikel lesen
07.04.21Norcros - Momentum maintained316Following the latest trading update, we have increased our earnings estimates again. Trading momentum is expected to continue beyond the year end and we now expect dividends to normalise more quickly....
► Artikel lesen
07.04.21Pharnext - Pivotal Phase III initiated401Pharnext announced on 31 March 2021 that it has enrolled its first patient in the pivotal Phase III study of PTX3003 for the treatment of Charcot-Marie-Tooth Disease (CMT) type Ia (the PREMIER study)....
► Artikel lesen
07.04.21Pixium Vision - Back to basics as Second Sight deal is called off559Pixium announced on 3 April that it had been notified by Second Sight of its unilateral decision to terminate the January 2021 memorandum of understanding (MOU) relating to the proposed business combination...
► Artikel lesen